Hiroshi Ohtsu
Overview
Explore the profile of Hiroshi Ohtsu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
190
Citations
3593
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miyazato K, Ohtsu H, Shimomura A, Yonemoto N, Shimizu C, Sase K, et al.
Breast
. 2025 Feb;
80:103894.
PMID: 39947088
No abstract available.
2.
Miyazato K, Ohtsu H, Shimomura A, Yonemoto N, Shimizu C, Sase K, et al.
Breast
. 2025 Jan;
79:103871.
PMID: 39754790
Standard trastuzumab therapy can reduce the risk of early recurrence of HER2-positive breast cancer. However, trastuzumab-induced cardiac dysfunction may force the discontinuation of adjuvant trastuzumab therapy. Incidentally, there are still...
3.
Homma Y, Yamasaki T, Tashiro K, Okada Y, Shirogane Y, Watari T, et al.
BMJ Open
. 2024 May;
14(5):e082243.
PMID: 38719293
Introduction: The femoral head contralateral to the collapsed femoral head requiring total hip arthroplasty (THA) often manifests in the precollapse stage of osteonecrosis of the femoral head (ONFH). It is...
4.
Bouchi R, Izumi K, Ishizuka N, Uemura Y, Ohtsu H, Miyo K, et al.
J Diabetes Investig
. 2024 May;
15(9):1287-1296.
PMID: 38712947
Aims: The utilization of long-term effect of internet of things (IoT) on glycemic control is controversial. This trial aimed to examine the effect of an IoT-based approach for type 2...
5.
Saita K, Sumitani M, Koyama Y, Sugita S, Matsubayashi Y, Ogata T, et al.
J Spinal Cord Med
. 2024 Feb;
:1-8.
PMID: 38391257
Background: In our published randomized controlled trial, we revealed that patients with acute ASIA Grade C incomplete cervical spinal cord injury (SCI) who underwent early surgery (within 24 h post-injury)...
6.
Uemura Y, Ozaki R, Shinozaki T, Ohtsu H, Shimizu Y, Izumi K, et al.
BMC Infect Dis
. 2023 Dec;
23(1):849.
PMID: 38049729
Background: The severity of coronavirus disease 2019 (COVID-19) infections has led to the development of several therapeutic agents, with tocilizumab becoming increasingly used to treat patients with COVID-19-related pneumonia. This...
7.
Terada M, Saito S, Kutsuna S, Kinoshita-Iwamoto N, Togano T, Hangaishi A, et al.
Life (Basel)
. 2023 Nov;
13(11).
PMID: 38004324
Convalescent plasma therapy, which involves administering plasma from recovered coronavirus disease 2019 (COVID-19) patients to infected individuals, is being explored as a potential treatment for severe cases of COVID-19. This...
8.
Iwase T, Saji S, Iijima K, Higaki K, Ohtani S, Sato Y, et al.
J Clin Oncol
. 2023 Apr;
41(18):3329-3338.
PMID: 37079878
Purpose: Treatment with an aromatase inhibitor for 5 years is the standard treatment for postmenopausal hormone receptor-positive breast cancer. We investigated the effects of extending this treatment to 10 years...
9.
Egawa M, Kanda E, Ohtsu H, Nakamura T, Yoshida M
J Atheroscler Thromb
. 2023 Jan;
30(10):1420-1426.
PMID: 36709997
Aim: Hypertensive disorders of pregnancy (HDP) are estimated to occur in up to 10% of all pregnancies and are associated with an increased risk of future cardiovascular disease (CVD) and...
10.
Homma Y, Zhuang X, Ohtsu H, Ishii S, Shirogane Y, Hayashi K, et al.
Int Orthop
. 2022 Nov;
47(1):187-192.
PMID: 36416898
Purpose: Acoustic analysis has recently been applied to cementless total hip arthroplasty (THA). The aim of this study was to develop a machine learning algorithm to predict post-operative subsidence with...